Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Patient dosing completed in phase II study of Alista for treatment of FSD

Aug. 27, 2001

Hormone replacement therapy has osteoprotective effects in elderly women

Aug. 27, 2001

Prevention of bone destruction by leflunomide

Aug. 24, 2001

Citrus flavonoid inhibits bone resorption

Aug. 24, 2001

Oxford GlycoSciences completes Vevesca NDA submission with FDA

Aug. 24, 2001

Alliance updates Oxygent development

Aug. 24, 2001

Synthetic vitamin D3, ED-71, significantly increases BMD, BMC and bone strength

Aug. 23, 2001

NPY5 receptor antagonists from Schering-Plough may be useful for treating obesity and diabetes

Aug. 23, 2001

Specific PPARgamma antagonist gives insight into receptor's role in adipogenesis

Aug. 23, 2001

Zometa approved by FDA for treatment of hypercalcemia of malignancy

Aug. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...